ライフサイエンスコーパス: pars plana vitrectomy

1 ervention (intravitreal injection, laser, or pars plana vitrectomy).

2 ge of sub-retinal fluid without the need for pars plana vitrectomy.

3 , or placebo 4 times daily for 3 days before pars plana vitrectomy.

4 4 eyes in 22 consecutive patients undergoing pars plana vitrectomy.

5 f patients undergoing cataract surgery after pars plana vitrectomy.

6 groups and subjected to standard three-port pars plana vitrectomy.

7 icenter trial compares scleral buckling with pars plana vitrectomy.

8 re indicated in several situations following pars plana vitrectomy.

9 treous samples were collected at the time of pars plana vitrectomy.

10 ften difficult to remove during conventional pars plana vitrectomy.

11 e to explant the XEN stent and perform early pars plana vitrectomy.

12 s detachment (PVD) is a critical step during pars plana vitrectomy.

13 Most eyes (62%) underwent pars plana vitrectomy.

14 ed to define the subretinal space, following pars plana vitrectomy.

15 ution) intravitreally applied during routine pars plana vitrectomy.

16 tional intravitreal antibiotic injections or pars plana vitrectomy.

17 ism and a patient with keratoconus following pars plana vitrectomy.

18 dogenous endophthalmitis (2/19, 10.5%), post-pars plana vitrectomy (1/19, 5.3%), and post-scleral buc

19 entions were phacoemulsification (20.8%) and pars plana vitrectomy (10.4%).

20 tial treatment was vitreous tap (49; 78%) or pars plana vitrectomy (14; 22%); all received intravitre

21 study was to assess the surgical outcomes of pars plana vitrectomy, 180 degrees inferior retinotomy a

22 eripheral anterior synechia, 3 eyes previous pars plana vitrectomy, 2 eyes aphakia, and 1 eye each wi

23 esent in 5 of 13 eyes (38%), including prior pars plana vitrectomy (3 eyes), history of retinal tear

24 of all patients had an ophthalmic procedure, pars plana vitrectomy (4.8%) being the most common one.

25 acuity (</=20/200 vs. >/=20/40, aHR, 1.47); pars plana vitrectomy (aHR, 1.87); history of OHT in the

26 Pars plana vitrectomy alone with complete drainage of su

27 chment, posterior synechia, and a history of pars plana vitrectomy also were associated with greater

28 Marfan syndrome, 2 (12%) were aphakic after pars plana vitrectomy and 4 (24%) were aphakic after sur

29 Associates, Newark, DE) suture and combined pars plana vitrectomy and compare predicted refractive o

30 sks, prognosis, and indications for diabetic pars plana vitrectomy and consider recent developments i

31 th microcystoid macular changes treated with pars plana vitrectomy and epiretinal and internal limiti

32 24 without glaucoma, underwent surgery with pars plana vitrectomy and epiretinal and internal limiti

33 Pars plana vitrectomy and ILM peeling have beneficial ef

34 RM and FTMH eyes that underwent surgery with pars plana vitrectomy and internal limiting membrane (IL

35 Reasonable treatment options include pars plana vitrectomy and intra-ocular antibiotics with

36 sclerotomy versus scleral tunnel) at time of pars plana vitrectomy and intraocular foreign body remov

37 of the decentered/dislocated IOL along with pars plana vitrectomy and intrascleral fixation of a 3-p

38 costeroid therapy may resolve some entities, pars plana vitrectomy and lensectomy may be necessary to

39 Pars plana vitrectomy and lensectomy were performed, alo

40 rior chamber intraocular lens (PCIOL) before pars plana vitrectomy and lensectomy.

41 Patients underwent pars plana vitrectomy and peeling of the internal limiti

42 y and safety between combined and sequential pars plana vitrectomy and phacoemulsification for macula

43 Cataract formation can occur following pars plana vitrectomy and pneumatic retinopexy.

44 net capsulotomy, and 3 eyes (15.8%) required pars plana vitrectomy and posterior capsulotomy.

45 Pars plana vitrectomy and PPV-SB as the first procedure

46 Pars plana vitrectomy and PPV/SB were performed on 138 e

47 rates with other surgical techniques such as pars plana vitrectomy and scleral buckle.

48 The procedures included were pars plana vitrectomy and scleral buckling.

49 and 56 weeks (follow-up, FUP) after 23 gauge pars plana vitrectomy and SF6 gas tamponade.

50 4 years of age with high-risk PRRD underwent pars plana vitrectomy and silicone oil injection with sc

51 The last patient had a pars plana vitrectomy and silicone oil instillation comb

52 Interventions included pars plana vitrectomy and silicone oil tamponade with or

53 Pars plana vitrectomy and tPA showed a clear advantage w

54 and 56 weeks (follow-up, FUP) after 23 gauge pars-plana vitrectomy and SF6 gas tamponade.

55 veitis, 1 prior hydrocephalus, 1 uveitis and pars plana vitrectomy, and 1 juvenile open-angle glaucom

56 All 15 patients had prior pars plana vitrectomy, and 14 patients (93%) had no lens

57 tic patients undergoing cataract extraction, pars plana vitrectomy, and intravitreal injections and t

58 The most frequent VR procedure was pars plana vitrectomy, and most common tamponade used wa

59 He had undergone pars plana vitrectomy, and SFIOL using silk sutures one-

60 tus, clear vitreous tap, cases not requiring pars plana vitrectomy, and those with Staphylococcus aur

61 ntravitreal injection of antibiotics or with pars plana vitrectomy at least twice were included.

62 hage, anterior vitrectomy at primary repair, pars plana vitrectomy at primary repair, and lensectomy

63 ined pars plana glaucoma drainage device and pars plana vitrectomy between November 2016 and Septembe

64 ess the effectiveness and safety of 23-gauge pars plana vitrectomy combined with phacoemulsification

65 vealed a trend toward a lower preference for pars plana vitrectomy compared to the West and South (P

66 Diabetic pars plana vitrectomy continues to advance with better a

67 ctors associated with IOP elevation included pars plana vitrectomy, contralateral IOP elevation (adju

68 of intravitreal antibiotics with or without pars plana vitrectomy (depending on the patient populati

69 dies show that particular surgeries, such as pars plana vitrectomy, Descemet stripping (automated) en

70 urgery in both eyes and underwent unilateral pars plana vitrectomy due to postcataract endophthalmiti

71 tical coherence tomography in patients after pars plana vitrectomy due to postcataract endophthalmiti

72 her pediatric ages), prior cataract surgery, pars plana vitrectomy, duration of uveitis >/=6 months,

73 rgical outcomes of single endoscopy-assisted pars plana vitrectomy (E-PPV) in patients with tractiona

74 The patient underwent urgent vitreous tap, pars plana vitrectomy, Endolaser, intravitreal antibioti

75 cryotherapy, scleral buckling at the time of pars plana vitrectomy, external drainage of the subretin

76 y for accurate evaluation of the efficacy of pars plana vitrectomy for BRVO.

77 ew published studies that report outcomes of pars plana vitrectomy for complications of BRVO consist

78 included 20 eyes from 20 patients undergoing pars plana vitrectomy for complications of PDR.

79 Pars plana vitrectomy for diabetic macular edema and for

80 ncluded 51 eyes of 51 patients who underwent pars plana vitrectomy for idiopathic MH.

81 28 eyes in 20 patients (all male) underwent pars plana vitrectomy for intraocular hemorrhages second

82 s undergoing a standard 20-gauge or 23-gauge pars plana vitrectomy for intraocular hemorrhages second

83 Patients who underwent pars plana vitrectomy for macula-off rhegmatogenous reti

84 Patients underwent pars plana vitrectomy for MFS.

85 accurately assess the risks and benefits of pars plana vitrectomy for proliferative diabetic retinop

86 t underwent combined phacoemulsification and pars plana vitrectomy for retinal detachment and later s

87 ctive cohort study of 506 eyes who underwent pars plana vitrectomy for rhegmatogenous retinal detachm

88 ion was performed at the slit lamp or during pars plana vitrectomy for telangiectasia visible at the

89 ect; 1 of these patients required subsequent pars plana vitrectomy for worsening clinical course.

90 Five patients required pars plana vitrectomy for worsening vitritis.

91 Vitreous fluids were collected during 23G pars plana vitrectomy from 54 eyes of 54 patients with d

92 25-Gauge pars plana vitrectomy has evolved significantly since it

93 ock hours, use of silicone oil tamponade for pars plana vitrectomy, history of choroidal detachment,

94 s in the culture group required a subsequent pars plana vitrectomy in 29 of 119 cases (24%) compared

95 nts, intravitreal antibiotics in 4 eyes, and pars plana vitrectomy in 4 eyes.

96 initial treatment in 57 of 63 (90%) eyes and pars plana vitrectomy in 6 of 63 (10%) eyes.

97 of the XEN stent in 5 patients (62.5%), and pars plana vitrectomy in 6 patients (75%).

98 on in 7 of 9 cases, removal of fibrosis with pars plana vitrectomy in all 9 patients, and implantatio

99 (1) phakic patients with history of pars plana vitrectomy in one eye as the only procedure;

100 olac 0.45%, 4 times daily, for 3 days before pars plana vitrectomy in the first 12 consecutive eyes.

101 elopment of suprachoroidal hemorrhage during pars plana vitrectomy include high myopia, history of pr

102 oscope-enabled intraoperative viewing during pars plana vitrectomy include posterior segment disease

103 udies will help dictate the future course of pars plana vitrectomy instrumentation.

104 intervention without success; subsequently, pars plana vitrectomy, internal limiting membrane peel a

105 All patients underwent pars plana vitrectomy, internal limiting membrane peelin

106 Fourteen eyes underwent pars plana vitrectomy, internal limiting membrane peelin

107 Pars plana vitrectomy is associated with clinically mean

108 uring scleral fixation surgery combined with pars plana vitrectomy leads to significantly less RPB, a

109 A complete pars plana vitrectomy may be required in order to reposi

110 ears to be that scleral buckling and primary pars plana vitrectomy may yield comparable single-operat

111 reous was collected from patients undergoing pars plana vitrectomy (n = 84).

112 ), secondary to multiple treatments (n = 7), pars-plana vitrectomy (n = 3), external-beam radiotherap

113 94 of 436 eyes (21.6%) with mean BCVA before pars plana vitrectomy of 20/78 and final follow-up BCVA

114 The surgical management using pars plana vitrectomy offers the most effective approach

115 Pars plana vitrectomy offers theoretical advantages but

116 uckle, pneumatic retinopexy, 25- or 27-gauge pars plana vitrectomy, or any combination of these techn

117 Intravitreal triamcinolone acetonide, pars plana vitrectomy, oral protein kinase C inhibitors

118 s associated with a higher rate of secondary pars plana vitrectomy (P = .009) and retinal detachment

119 quentially performed phacoemulsification and pars plana vitrectomy (phaco-PPV).

120 ntial to condense three separate procedures: pars plana vitrectomy, phacoemulsification, and YAG caps

121 avitreal injections of aflibercept, 2 mg, vs pars plana vitrectomy plus panretinal photocoagulation f

122 Pars plana vitrectomy plus SB yielded a significantly hi

123 The management options for VMT include pars plana vitrectomy, pneumatic vitreolysis, enzymatic

124 Following prior pars plana vitrectomy, pO(2) levels were significantly h

125 ship between different indications for trans pars plana vitrectomies (PPV's) and the intraocular pres

126 le scleral buckling (SB group - 12 eyes), or pars plana vitrectomy (PPV group - 21 eyes).

127 edictive of disease remission included prior pars plana vitrectomy (PPV) (hazard ratio [HR] [vs no PP

128 buckle (SB) alone was performed in 75 eyes, pars plana vitrectomy (PPV) + SB was performed in 27 eye

129 was done either by scleral buckling (SB) or pars plana vitrectomy (PPV) according to the topography

130 e differences in safety and efficacy between pars plana vitrectomy (PPV) alone and PPV with a supplem

131 genous retinal detachment (RRD) repair using pars plana vitrectomy (PPV) alone versus combined sclera

132 All cases were treated with pars plana vitrectomy (PPV) and a double silicone oil en

133 (30 women, 26 men) that underwent successful pars plana vitrectomy (PPV) and internal limiting membra

134 ring with retinal flattening were treated by pars plana vitrectomy (PPV) and silicone oil injection.

135 Nondiabetic eyes undergoing pars plana vitrectomy (PPV) and silicone oil tamponade w

136 eded-a standardised secondary procedure with pars plana vitrectomy (ppV) and subretinal rtPA.

137 All patients with RRD who underwent pars plana vitrectomy (PPV) between January 2013 and Dec

138 Venous air embolism (VAE) during pars plana vitrectomy (PPV) can occur owing to improper

139 tioning (FDP) for 3-6 months or longer after pars plana vitrectomy (PPV) combined with silicone oil (

140 Pars plana vitrectomy (PPV) continues to demonstrate eff

141 ctive case series of eyes undergoing primary pars plana vitrectomy (PPV) for common vitreoretinal ind

142 l and visual outcomes in patients undergoing pars plana vitrectomy (PPV) for diabetic TRD.

143 ane (ERM) and could influence the results of pars plana vitrectomy (PPV) for ERM removal in pseudopha

144 The procedures included pars plana vitrectomy (PPV) for macular pucker, vitreous

145 rence tomography data (iOCT) in all steps of pars plana vitrectomy (PPV) for non-RRD in MGS, in order

146 2) panretinal photocoagulation (PRP), or (3) pars plana vitrectomy (PPV) for PDR; and study eye chang

147 educed vertical metamorphopsia compared with pars plana vitrectomy (PPV) for primary rhegmatogenous r

148 dergone either pneumatic retinopexy (PnR) or pars plana vitrectomy (PPV) for rhegmatogenous retinal d

149 nce of microcystic macular edema (MME) after pars plana vitrectomy (PPV) for rhegmatogenous retinal d

150 scularity index (CVI) in patients undergoing pars plana vitrectomy (PPV) for rhegmatogenous retinal d

151 FCL) versus posterior retinotomy (PR) during pars plana vitrectomy (PPV) for RRD, focusing on anatomi

152 erwent 23 gauge transconjunctival sutureless pars plana vitrectomy (PPV) for serous macular detachmen

153 ministration in diabetic subjects undergoing pars plana vitrectomy (PPV) for severe manifestations of

154 in the 5 eyes with subhyaloid hemorrhage and pars plana vitrectomy (PPV) for the eyes with FTMH and e

155 utcomes of pneumatic retinopexy (PnR) versus pars plana vitrectomy (PPV) for the management of primar

156 rative diabetic retinopathy (PDR) undergoing pars plana vitrectomy (PPV) for vitreous hemorrhage (VH)

157 Previous pars plana vitrectomy (PPV) had been performed in 3 eyes

158 Pars plana vitrectomy (PPV) has been reported to reduce

159 (SB) in 49 (81.7%) eyes and combined SB and pars plana vitrectomy (PPV) in 11 (18.3%) eyes.

160 ar film osmolarity after micro-incision 25G+ pars plana vitrectomy (PPV) in a prospective study.

161 Pars plana vitrectomy (PPV) in eyes with history of reti

162 To report longer-term outcomes of 27-gauge pars plana vitrectomy (PPV) in eyes with posterior segme

163 effectiveness of prophylactic laser or early pars plana vitrectomy (PPV) in preventing retinal detach

164 Although pars plana vitrectomy (PPV) is a widely used treatment m

165 Primary pars plana vitrectomy (PPV) is often performed by vitreo

166 Pars plana vitrectomy (PPV) is preferred surgical proced

167 Pars plana vitrectomy (PPV) is the treatment of choice f

168 procedural code for intravitreal injections, pars plana vitrectomy (PPV) or laser treatment in their

169 genous retinal detachment (RRD) treated with pars plana vitrectomy (PPV) or PPV with scleral buckle (

170 in patients with IOFBs that we extracted by pars plana vitrectomy (PPV) over a 5-year period.

171 Patients with lensectomy or pars plana vitrectomy (PPV) prior to cataract surgery we

172 higher rates of combined scleral buckle (SB)/pars plana vitrectomy (PPV) repairs (14% vs. 3%, P < 0.0

173 By comparison, vitreous samples obtained by pars plana vitrectomy (PPV) resulted in fungus-positive

174 When pars plana vitrectomy (PPV) was selected as the primary

175 Patients undergoing pars plana vitrectomy (PPV) were more likely to develop

176 ercent of eyes (n = 12) underwent an initial pars plana vitrectomy (PPV) with intravitreal antibiotic

177 Eyes undergoing pars plana vitrectomy (PPV) with membrane peel (MP) surg

178 Small-gauge pars plana vitrectomy (PPV) with or without a scleral bu

179 e morphological and functional results after pars plana vitrectomy (PPV) with sulfur hexafluoride (SF

180 and at 12 months after SMH, eyes undergoing pars plana vitrectomy (PPV) within 30 days of SMH, and V

181 Of 3403 operations, 2693 (79.1%) were pars plana vitrectomy (PPV), 413 (12.1%) were retinopexy

182 Twenty-five percent of patients underwent pars plana vitrectomy (PPV), 50% underwent encircling sc

183 To compare outcomes of scleral buckle (SB), pars plana vitrectomy (PPV), and combined PPV-SB to trea

184 ocedures were compared, including repeat PR, pars plana vitrectomy (PPV), and combined scleral buckle

185 g a subsequent ocular intervention including pars plana vitrectomy (PPV), and complex RD repair withi

186 atic retinopexy (PR), scleral buckling (SB), pars plana vitrectomy (PPV), and laser prophylaxis were

187 B treatment prior to the study, a history of pars plana vitrectomy (PPV), and less than 1 year of fol

188 y (<=1month post-trauma), delayed (>1 month) pars plana vitrectomy (PPV), and observation.

189 The primary outcome was the need for pars plana vitrectomy (PPV), defined by Current Procedur

190 tear (GRT) more than 180 degrees by combined pars plana vitrectomy (PPV), encircling scleral buckle,

191 patient underwent surgical intervention with pars plana vitrectomy (PPV), internal limiting membrane

192 Surgical treatment involves pars plana vitrectomy (PPV), often combined with adjunct

193 umatic retinopexy (PR), scleral buckle (SB), pars plana vitrectomy (PPV), or combined PPV/SB and subs

194 Ds) can be treated with scleral buckle (SB), pars plana vitrectomy (PPV), or SB combined with PPV (PP

195 re was postoperative visual acuity following pars plana vitrectomy (PPV), scleral buckle (SB), or com

196 with sequential, bilateral RRD treated with pars plana vitrectomy (PPV), scleral buckle (SB), or PPV

197 retinal detachment (RD) surgical repair via pars plana vitrectomy (PPV), scleral buckle (SB), or PPV

198 with sequential, bilateral RRD treated with pars plana vitrectomy (PPV), scleral buckle (SB), or PPV

199 All patients undergoing pars plana vitrectomy (PPV), scleral buckling (SB), and

200 All operations included a pars plana vitrectomy (PPV)-41.1% with hexafluoroethane

201 luoropropane (C(3)F(8)) as an alternative to pars plana vitrectomy (PPV).

202 and 8 patients (67%) subsequently underwent pars plana vitrectomy (PPV).

203 Symptomatic patients underwent pars plana vitrectomy (PPV).

204 isorders are being successfully managed with pars plana vitrectomy (PPV).

205 is is a rare but devastating complication of pars plana vitrectomy (PPV).

206 isual impairment, necessitating a subsequent pars plana vitrectomy (PPV).

207 rates of cataract extraction (CE) following pars plana vitrectomy (PPV).

208 Patients with primary RRD operated with pars plana vitrectomy (PPV).

209 repair with either scleral buckling (SB) or pars plana vitrectomy (PPV).

210 Twenty-six eyes underwent pars plana vitrectomy (PPV).

211 Intravitreal antifungal injection, pars plana vitrectomy (PPV).

212 All 15 eyes underwent pars plana vitrectomy (PPV): 6 for vitreous hemorrhage (

213 Interventions for RRD repair included pars plana vitrectomy (PPV; 15 patients), combined scler

214 , 2.2; 95% CI, 1.1-4.5) and combined SB plus pars plana vitrectomy (PPV; 68%; OR, 2.3; 95% CI, 1.1-5.

215 Patients who underwent standard or complex pars plana vitrectomy (PPV; Current Procedural Terminolo

216 patients with macula-on RRDs, who underwent pars-plana-vitrectomy (ppV) with SO tamponade were retro

217 cal intervention (pneumatic retinopexy [PR], pars plana vitrectomy [PPV], laser barricade, or scleral

218 omes and safety of transconjuctival 23-gauge pars plana vitrectomy(PPV) for removal of intraocular fo

219 cular(IOL) fixation techniques combined with pars plana vitrectomy(PPV) from a single tertiary referr

220 To determine the impact of total pars plana vitrectomies (PPVs) with peripheral shaving o

221 Pars plana vitrectomy procedure has showed a better visu

222 Pars plana vitrectomy procedures between January 1, 2013

223 r regions (P < .01) and lower preference for pars plana vitrectomy relative to the South and West (P

224 All eyes underwent pars plana vitrectomy, removal of any epiretinal membran

225 Pars plana vitrectomy required a significantly higher nu

226 ents had E-PPV, and 43 patients had standard pars plana vitrectomy [S-PPV]).

227 ess was 72.4% with combined scleral buckling/pars plana vitrectomy (SB/PPV; N = 29) compared with 47.

228 Pars plana vitrectomy-SB showed less improvement in visi

229 e surgical management of RD usually involves pars plana vitrectomy, scleral buckling or pneumatic ret

230 preference for retinal detachment repair by pars plana vitrectomy, scleral buckling, and pneumatic r

231 cluded: posterior dislocations necessitating pars plana vitrectomy; secondary implantations for aphak

232 Previous scleral buckling or pars plana vitrectomy seem to have no impact on the succ

233 The patient underwent pars plana vitrectomy, subluxated cataract explantation,

234 Prior to the invention of pars plana vitrectomy, such surgery was innovative, even

235 atomical alterations imposed by the previous pars plana vitrectomy surgery and the underlying vitreor

236 Pars plana vitrectomy surgery was performed for the prog

237 xel-induced phototoxic maculopathy following pars plana vitrectomy surgery.

238 e is an uncommon but serious complication of pars plana vitrectomy that can be associated with a guar

239 n eyes with suprachoroidal hemorrhage during pars plana vitrectomy, the final visual and anatomic out

240 groups: control subjects (n = 3) undergoing pars plana vitrectomy to remove an epiretinal membrane (

241 Techniques such as trans pars plana vitrectomy (TPPV), macular buckle (MB), and c

242 of pars plana glaucoma drainage devices with pars plana vitrectomy using one of the vitrectomy sclero

243 s of pars plana glaucoma drainage device and pars plana vitrectomy using one of the vitrectomy sclero

244 Pars plana vitrectomy usually was performed in patients

245 With regard to management, pars plana vitrectomy was associated with increased prob

246 Pars plana vitrectomy was frequently performed regardles

247 Pars plana vitrectomy was most common (49%), followed by

248 ents and final anatomical reattachment after pars plana vitrectomy was obtained in 100% of patients.

249 Pars plana vitrectomy was performed in 9 eyes (6%) with

250 Pars plana vitrectomy was performed in 94 of 436 eyes (2

251 A 25-gauge pars plana vitrectomy was performed in all cases, with a

252 A 23-gauge pars plana vitrectomy was performed with peeling of the

253 Next, a pars plana vitrectomy was performed, and the electrode a

254 equired repeat grafting, and in 6 of 8 eyes, pars plana vitrectomy was used to remove the dislocated

255 Subretinal injection with pars plana vitrectomy was well tolerated in this cohort.

256 Vitreous biopsy, followed by 25-gauge pars plana vitrectomy, was performed in the same sitting

257 he procedure was unsuccessful, necessitating pars plana vitrectomy, while in a case with proliferativ

258 atients with light perception should receive pars plana vitrectomy, while those with hand motion and

259 Pars plana vitrectomy will probably remain the treatment

260 h intravitreal injections of antibiotics and pars plana vitrectomies with intravitreal antibiotics.

261 pathic macular holes that underwent 23-gauge pars plana vitrectomy with 2 cc pure SF6 gas tamponade.

262 Either pars plana vitrectomy with 24-gray EMB and ongoing pro r

263 year-old lady with a stage IV FTMH underwent pars plana vitrectomy with 25 gauge plus transconjunctiv

264 Participants underwent pars plana vitrectomy with a single 24-gray dose of epim

265 Participants underwent pars plana vitrectomy with a single 24-Gy dose of EMB de

266 All consecutive patients underwent pars plana vitrectomy with a superiorly based inverted I

267 More recently, pars plana vitrectomy with adventitial sheathotomy has a

268 The primary anatomical success rates for pars plana vitrectomy with and without scleral buckle (P

269 Pars plana vitrectomy with creation of an inner retinal

270 In glaucomatous eyes, pars plana vitrectomy with epiretinal and internal limit

271 The vitrectomy group additionally underwent pars plana vitrectomy with epiretinal membrane or ILM pe

272 Lamellar macular hole surgery involves pars plana vitrectomy with epiretinal membrane or prolif

273 Pars plana vitrectomy with ERM removal and ILM peeling w

274 iterature of FIL SSF IOL opacification after pars plana vitrectomy with gas tamponade for retinal det

275 Ten patients who underwent standard 3-port pars plana vitrectomy with gas tamponade to repair rhegm

276 Surgeon method included 23-gauge or 25-gauge pars plana vitrectomy with induction of posterior vitreo

277 Pars plana vitrectomy with internal limiting membrane pe

278 Patients underwent pars plana vitrectomy with internal limiting membrane pe

279 etinopathy is now most frequently treated by pars plana vitrectomy with intraoperative peeling of mem

280 travitreal antibiotic injection (n = 12) and pars plana vitrectomy with intravitreal antibiotic injec

281 ntravitreal antibiotic injection (n = 5) and pars plana vitrectomy with intravitreal antibiotic injec

282 nal abscess is smaller than four disc areas, pars plana vitrectomy with intravitreal injection of ant

283 A pars plana vitrectomy with intravitreal injection of cef

284 orrhage presents a 76% increased profit over pars plana vitrectomy with laser, with equivalent functi

285 etinal membrane formation, for which she had pars plana vitrectomy with membrane peeling.

286 Pars plana vitrectomy with or without delamination/segme

287 7 patients with idiopathic ERM who underwent pars plana vitrectomy with peeling of the ERM from 2019

288 tients in both groups underwent conventional pars plana vitrectomy with peeling of the internal limit

289 Combining pars plana vitrectomy with phacoemulsification and poste

290 Combined 23-gauge pars plana vitrectomy with phacoemulsification for prima

291 For eyes undergoing pars plana vitrectomy with scleral-sutured IOL implantat

292 received surgery (pneumatic retinopexy [PR], pars plana vitrectomy with silicone oil [PPV+SO], or scl

293 l detachment underwent an uneventful primary pars plana vitrectomy with silicone oil endotamponade on

294 Pars plana vitrectomy with SO tamponade with or without

295 genous retinal detachment underwent 23-gauge pars plana vitrectomy with subretinal fluid drainage thr

296 All patients underwent a pars plana vitrectomy with subretinal implantation of hu

297 Pars plana vitrectomy with supplemental SB was associate

298 gical treatments for sub macular hemorrhage, pars plana vitrectomy with tissue plasminogen activator

299 um diameter > 400 mum) treated with 25-gauge pars-plana vitrectomy with either complete ILM peeling (

300 Eleven patients (85%) underwent a pars plana vitrectomy within 24 h.